发热待查诊治专家共识

2017-11-20 《中华传染病杂志》编辑委员会 中华传染病杂志.2017.35(11):641-655.

“发热待查”是感染科疑难疾病诊治中的难点。合理临床诊治流程可以提高发热待查的诊断水平。为规范发热待查临床诊治流程,《中华传染病杂志》编辑委员会根据发热待查的特点、国内外最新的循证医学证据,于2016年组织国内有关专家对发热待查的诊治流程进行了讨论,并形成《发热待查诊治专家共识》(以下简称共识)。本共识旨在帮助临床医师在发热待查的诊断与治疗中做出合理决策,但本共识不是强制性标准,也不可能包括或解决发

中文标题:

发热待查诊治专家共识

发布日期:

2017-11-20

简要介绍:

“发热待查”是感染科疑难疾病诊治中的难点。合理临床诊治流程可以提高发热待查的诊断水平。为规范发热待查临床诊治流程,《中华传染病杂志》编辑委员会根据发热待查的特点、国内外最新的循证医学证据,于2016年组织国内有关专家对发热待查的诊治流程进行了讨论,并形成《发热待查诊治专家共识》(以下简称共识)。本共识旨在帮助临床医师在发热待查的诊断与治疗中做出合理决策,但本共识不是强制性标准,也不可能包括或解决发热待查中的所有问题。因此,临床医师在面对具体患者时,应根据自己的专业知识、临床经验和可利用的医疗资源,制定全面合理的诊疗方案。未来将根据国内外的有关进展,继续对本共识进行修订和完善。

 

拓展指南:发热相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=发热待查诊治专家共识)] GetToolGuiderByIdResponse(projectId=1, id=dcb6d1c001566021, title=发热待查诊治专家共识, enTitle=, guiderFrom=中华传染病杂志.2017.35(11):641-655., authorId=null, author=, summary=“发热待查”是感染科疑难疾病诊治中的难点。合理临床诊治流程可以提高发热待查的诊断水平。为规范发热待查临床诊治流程,《中华传染病杂志》编辑委员会根据发热待查的特点、国内外最新的循证医学证据,于2016年组织国内有关专家对发热待查的诊治流程进行了讨论,并形成《发热待查诊治专家共识》(以下简称共识)。本共识旨在帮助临床医师在发热待查的诊断与治疗中做出合理决策,但本共识不是强制性标准,也不可能包括或解决发, cover=, journalId=null, articlesId=null, associationId=1610, associationName=《中华传染病杂志》编辑委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Nov 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>“发热待查”是感染科疑难疾病诊治中的难点。合理临床诊治流程可以提高发热待查的诊断水平。为规范发热待查临床诊治流程,《中华传染病杂志》编辑委员会根据发热待查的特点、国内外最新的循证医学证据,于2016年组织国内有关专家对发热待查的诊治流程进行了讨论,并形成《发热待查诊治专家共识》(以下简称共识)。本共识旨在帮助临床医师在发热待查的诊断与治疗中做出合理决策,但本共识不是强制性标准,也不可能包括或解决发热待查中的所有问题。因此,临床医师在面对具体患者时,应根据自己的专业知识、临床经验和可利用的医疗资源,制定全面合理的诊疗方案。未来将根据国内外的有关进展,继续对本共识进行修订和完善。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>发热</FONT>相关指南:</STRONG><BR> <UL> <LI><A title=发热伴肺部阴影诊断的问题与共识 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=106311c001a05443">发热伴肺部阴影诊断的问题与共识</A> <LI><A title=发热伴肺部阴影鉴别诊断专家共识 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=ac4df1c001a05339">发热伴肺部阴影鉴别诊断专家共识</A> <LI><A title="2016 SIP指南:儿童发热的管理(更新版)" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=99c281c00132a5a8">2016 SIP指南:儿童发热的管理(更新版)</A> <LI><A title="2016 ESMO临床实践指南:发热性中性粒细胞减少的管理" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=fb6f61c001288ab8">2016 ESMO临床实践指南:发热性中性粒细胞减少的管理</A> <LI><A title="2016 ACR适宜性标准:儿童无源性或不明原因发热" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=ed5b41c00128e825">2016 ACR适宜性标准:儿童无源性或不明原因发热</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E5%8F%91%E7%83%AD">有关发热更多指南</A></LI></UL>, tagList=[TagDto(tagId=71433, tagName=发热待查)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12787, appHits=2392, showAppHits=39, pcHits=6877, showPcHits=5242, likes=91, shares=213, comments=14, approvalStatus=1, publishedTime=Sat Mar 10 21:53:01 CST 2018, publishedTimeString=2017-11-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 10 21:53:01 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 15:07:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=发热待查诊治专家共识)])
发热待查诊治专家共识
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2104706, encodeId=94572104e06c7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/d597f0650de14ae883c12f76001689fc/a9cb053df3f94eb28148eabb3d84ecf1.jpg, createdBy=eb1a5106463, createdName=胖达盼盼, createdTime=Wed Dec 07 10:09:07 CST 2022, time=2022-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083102, encodeId=d70c108310245, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tNAmMmIN8MMzffXVMWzYZepvpj5S4icRwH5Yf1zxRACiaupGPueIk1xvszI41S7FwklCopLCiazU47SbticmkGoVUA/132, createdBy=0c9e5313467, createdName=韦名扬, createdTime=Wed Dec 22 15:57:25 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058986, encodeId=00de1058986ff, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 15:55:00 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973507, encodeId=6e889e35078d, content=积分aaaaaaaaa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/3916985120f34070adda73bbb5e2533f/e055b79d74214de1867bcea8875594c4.jpg, createdBy=807d5520683, createdName=QAQyyds, createdTime=Mon Jun 14 18:07:55 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960703, encodeId=d7e8960e03dd, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e425378338, createdName=ms8000000237709935, createdTime=Mon Apr 26 18:55:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2022-12-07 胖达盼盼 来自河北省

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2104706, encodeId=94572104e06c7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/d597f0650de14ae883c12f76001689fc/a9cb053df3f94eb28148eabb3d84ecf1.jpg, createdBy=eb1a5106463, createdName=胖达盼盼, createdTime=Wed Dec 07 10:09:07 CST 2022, time=2022-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083102, encodeId=d70c108310245, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tNAmMmIN8MMzffXVMWzYZepvpj5S4icRwH5Yf1zxRACiaupGPueIk1xvszI41S7FwklCopLCiazU47SbticmkGoVUA/132, createdBy=0c9e5313467, createdName=韦名扬, createdTime=Wed Dec 22 15:57:25 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058986, encodeId=00de1058986ff, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 15:55:00 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973507, encodeId=6e889e35078d, content=积分aaaaaaaaa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/3916985120f34070adda73bbb5e2533f/e055b79d74214de1867bcea8875594c4.jpg, createdBy=807d5520683, createdName=QAQyyds, createdTime=Mon Jun 14 18:07:55 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960703, encodeId=d7e8960e03dd, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e425378338, createdName=ms8000000237709935, createdTime=Mon Apr 26 18:55:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-12-22 韦名扬

    这个好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2104706, encodeId=94572104e06c7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/d597f0650de14ae883c12f76001689fc/a9cb053df3f94eb28148eabb3d84ecf1.jpg, createdBy=eb1a5106463, createdName=胖达盼盼, createdTime=Wed Dec 07 10:09:07 CST 2022, time=2022-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083102, encodeId=d70c108310245, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tNAmMmIN8MMzffXVMWzYZepvpj5S4icRwH5Yf1zxRACiaupGPueIk1xvszI41S7FwklCopLCiazU47SbticmkGoVUA/132, createdBy=0c9e5313467, createdName=韦名扬, createdTime=Wed Dec 22 15:57:25 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058986, encodeId=00de1058986ff, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 15:55:00 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973507, encodeId=6e889e35078d, content=积分aaaaaaaaa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/3916985120f34070adda73bbb5e2533f/e055b79d74214de1867bcea8875594c4.jpg, createdBy=807d5520683, createdName=QAQyyds, createdTime=Mon Jun 14 18:07:55 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960703, encodeId=d7e8960e03dd, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e425378338, createdName=ms8000000237709935, createdTime=Mon Apr 26 18:55:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-10-09 13bfbbb4m94暂无昵称

    积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2104706, encodeId=94572104e06c7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/d597f0650de14ae883c12f76001689fc/a9cb053df3f94eb28148eabb3d84ecf1.jpg, createdBy=eb1a5106463, createdName=胖达盼盼, createdTime=Wed Dec 07 10:09:07 CST 2022, time=2022-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083102, encodeId=d70c108310245, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tNAmMmIN8MMzffXVMWzYZepvpj5S4icRwH5Yf1zxRACiaupGPueIk1xvszI41S7FwklCopLCiazU47SbticmkGoVUA/132, createdBy=0c9e5313467, createdName=韦名扬, createdTime=Wed Dec 22 15:57:25 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058986, encodeId=00de1058986ff, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 15:55:00 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973507, encodeId=6e889e35078d, content=积分aaaaaaaaa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/3916985120f34070adda73bbb5e2533f/e055b79d74214de1867bcea8875594c4.jpg, createdBy=807d5520683, createdName=QAQyyds, createdTime=Mon Jun 14 18:07:55 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960703, encodeId=d7e8960e03dd, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e425378338, createdName=ms8000000237709935, createdTime=Mon Apr 26 18:55:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-06-14 QAQyyds

    积分aaaaaaaaa

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2104706, encodeId=94572104e06c7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/d597f0650de14ae883c12f76001689fc/a9cb053df3f94eb28148eabb3d84ecf1.jpg, createdBy=eb1a5106463, createdName=胖达盼盼, createdTime=Wed Dec 07 10:09:07 CST 2022, time=2022-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083102, encodeId=d70c108310245, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tNAmMmIN8MMzffXVMWzYZepvpj5S4icRwH5Yf1zxRACiaupGPueIk1xvszI41S7FwklCopLCiazU47SbticmkGoVUA/132, createdBy=0c9e5313467, createdName=韦名扬, createdTime=Wed Dec 22 15:57:25 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058986, encodeId=00de1058986ff, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 15:55:00 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973507, encodeId=6e889e35078d, content=积分aaaaaaaaa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/3916985120f34070adda73bbb5e2533f/e055b79d74214de1867bcea8875594c4.jpg, createdBy=807d5520683, createdName=QAQyyds, createdTime=Mon Jun 14 18:07:55 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960703, encodeId=d7e8960e03dd, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e425378338, createdName=ms8000000237709935, createdTime=Mon Apr 26 18:55:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-04-26 ms8000000237709935

    学习了,受益匪浅

    0